Related Experiment Videos
Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma
F J Pomares1, R Cañas, J M Rodriguez
1Department of Endocrinology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
Clinical Endocrinology
|May 14, 1998
Summary
Sporadic and familial phaeochromocytomas present differently, with familial types diagnosed earlier and often asymptomatically. Imaging reveals key differences, particularly bilaterality in MEN 2A cases, guiding distinct surgical approaches.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Phaeochromocytoma can be sporadic or linked to inherited syndromes like Multiple Endocrine Neoplasia type 2A (MEN 2A).
- Understanding differences between these forms is crucial for diagnosis and management.
Purpose of the Study:
- To investigate and compare clinical, pathological, and imaging differences between sporadic and MEN 2A phaeochromocytomas.
Main Methods:
- A retrospective analysis of 46 phaeochromocytoma patients (23 sporadic, 23 familial/MEN 2A) from 1979-1995.
- Data collected included age, presentation, clinical features, diagnostics, treatment, and follow-up.
Main Results:
- Familial phaeochromocytomas presented at a younger age (38 vs. 47 years) and often asymptomatically (52% vs. 17% for sporadic).
- Computed tomography identified 100% of sporadic tumors but only 76% of familial ones, which were frequently bilateral (100% vs. 0%).
- Diagnostic confirmation rates were high for both types via 24-hour urine analysis of catecholamines and metanephrines.
Conclusions:
- Significant differences exist between sporadic and MEN 2A phaeochromocytomas in age of onset, presentation, imaging characteristics (especially bilaterality), and surgical strategy.
- These distinctions necessitate tailored diagnostic and therapeutic approaches for each subtype.